Effect of Devdarvyadi Choorna in Prostate enlargement

Phase 2

Not yet recruiting

• Conditions: Benign prostatic hyperplasia without lower urinary tract symptoms. Ayurveda Condition: VATASHTHILA,

• Registration Number: CTRI/2022/01/039716
• Lead Sponsor: Saroj Kumar Mukhiya

Brief Summary

Diagnosed BPH(Benign Prostate Hyperplasia) will be treated with 2 groups,Group A- Trial Group Drug- Devdarvyadi Choorna 5g twice a day Koshna jal for 30 days and Group B- Controlled group Drug- Tab Tamsulosin Hydrochloride 0.4mg at bed time(night) daily with lukewarm water for 30 days.30 patients will be taken in each group.Assessment criteria for study will be the patients fulfilling the diagnostic criteria and sign and symptoms of Vatashthilla with special reference to BPH,such as those patients willing to participate into the study,male patients of age between 50-75yrs.This disease is characterized by both obstructive symptoms like dribbling MicturItion, hesistancy,weak flow of urine stream and irritative symptoms like increase frequency of micturition,nocturnal incontinence and urgency of Micturation. These symptoms causes disturbances in work sleep and concentration and ultimately reduce the patients quality of life.Devdarvyadi Choorna  is drug of choice for Vatashthila which contain all the necessary  ingredients that are useful to breakdown pathophysiology of Vatashthila by their rasa and virya, vipak properties. Ayurveda Samhita gives us the opportunity to treat the Vatashthila.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-02
• Last Update Posted: 2022-01-20

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Male
• Target Recruitment: 60

Inclusion Criteria

• Patient with clinical features of BPH like Reduced urinary flow Hesistancy Urgency of micturition Nocturia Increased frequency of micturition.
• Patiens having post voiding residual volume from 50ml to 200ml.
• Patients having International Prostate Symptom score(IPSS) Mild to moderate (IPSS<19) Patient willing to participate in clinical study.

Exclusion Criteria

• Diagnosed case of malignancy of prostate.
• Diagnosed case of urethral stricture.
• Active Urinary tract infection.
• Patients with uncontrolled Diabetes Mellitus,T.B.,Malignancy,HBV.
• Patients with impaired renal functions.
• Other systemic disorders which can interfere with the course of treatment.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in the size of prostate	30 days
Decrease in the severity in sign and symptoms of BPH	30 days

Secondary Outcome Measures

Name	Time	Method
reduction in sign and symptoms	30 days

Trial Locations

Locations (1)

Arogyashala Rugnalaya Nashik; 🇮🇳 Nashik, MAHARASHTRA, India

Arogyashala Rugnalaya Nashik

🇮🇳Nashik, MAHARASHTRA, India

Saroj Kumar Mukhiya

Principal investigator

8449503173

sarojmukhiya1995@gmail.com